Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial.

@article{Tehranchi2013EffectsOT,
  title={Effects of terazosin and tolterodine on ureteral stent related symptoms: a double-blind placebo-controlled randomized clinical trial.},
  author={Ali Tehranchi and Yousef Rezaei and Hamidreza Khalkhali and Mahdi Rezaei},
  journal={International braz j urol : official journal of the Brazilian Society of Urology},
  year={2013},
  volume={39 6},
  pages={832-40}
}
OBJECTIVE To evaluate the effects of terazosin and tolterodine on ureteral stent discomfort. MATERIALS AND METHODS Of 163 patients assessed for eligibility, 104 patients were randomly assigned to receive placebo, 2 mg of terazosin twice daily, 2 mg of tolterodine daily, or both terazosin plus tolterodine during the stenting period. Prior to stenting and at stent removal, the International Prostate Symptom Score (IPSS), the IPSS quality of life (QoL) subscore and the Visual Analog Scale for… CONTINUE READING